Sangamo BioSciences | Spese Operative



Operating Expenses Cambiamento Data
Alaunos Therapeutics USD 759K 391K 2024-12
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amgen USD 6.86B 85M 2025-03
Bayer EUR 11.41B 3.22B 2025-03
Biogen USD 2.12B 106.5M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Cipla INR 55.01B 1.37B 2025-03
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 8.95M 3.68M 2024-12
CSL USD 5.72B 173M 2024-12
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Grifols EUR 1.6B 128.03M 2024-12
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
J&J USD 8.26B 10.37B 2025-03
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Tectonic Therapeutic USD 13.99M 5.65M 2024-12
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Sangamo BioSciences Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.